bupropion has been researched along with vanoxerine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffman, BT; Katz, JL; Kopajtic, T; Newman, AH | 1 |
| Acharya, S; Cheon, SH; Kim, KM; Paudel, S; Yoon, G | 1 |
| Acharya, S; Cheon, SH; Khadka, DB; Kim, KM; Min, X; Paudel, S; Yoon, G | 1 |
| Beauregard, M; Descarries, L; Ferron, A | 1 |
| Bergman, J; Johnson, SE; Madras, BK; Spealman, RD | 1 |
| Kruk, ZL; Millar, J; Stamford, JA | 1 |
| Kuhr, WG; May, LJ; Wightman, RM | 1 |
| Gorelick, DA | 1 |
| Carroll, FI; Damaj, MI; Martin, BR; Slemmer, JE | 1 |
| Moser, A; Qadri, F; Sarkar, R; Thümen, A | 1 |
| Broadbent, J; Kampmueller, KM; Koonse, SA | 1 |
| Bevins, RA; Linkugel, JD; Reichel, CM | 1 |
| Cools, AR; Deen, PM; Ellenbroek, BA; Olivier, B; Olivier, JD | 1 |
| Balci, F; Campbell, U; Hanania, T; Olivier, BE; Paterson, NE | 1 |
| Eriksson, O; Josephsson, R; Långström, B | 1 |
| Collins, SL; Contreras-Mora, HM; Correa, M; Errante, EL; Rowland, MA; Salamone, JD; Yohn, SE | 1 |
16 other study(ies) available for bupropion and vanoxerine
| Article | Year |
|---|---|
2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors.
Topics: Algorithms; Binding, Competitive; Carrier Proteins; Databases, Factual; Dopamine; Dopamine Plasma Membrane Transport Proteins; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Models, Molecular; Nerve Tissue Proteins; Quantitative Structure-Activity Relationship; Radioligand Assay; Reproducibility of Results; Software | 2000 |
Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors.
Topics: HEK293 Cells; Humans; In Vitro Techniques; Neurotransmitter Uptake Inhibitors; Piperazines; Piperidines | 2017 |
Triple reuptake inhibitors: Design, synthesis and structure-activity relationship of benzylpiperidine-tetrazoles.
Topics: Dopamine; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Docking Simulation; Molecular Structure; Neurotransmitter Uptake Inhibitors; Norepinephrine; Piperidines; Serotonin; Structure-Activity Relationship; Tetrazoles | 2017 |
Comparative analysis of the effects of iontophoretically applied dopamine in different regions of the rat brain, with special reference to the cingulate cortex.
Topics: alpha-Methyltyrosine; Animals; Brain; Bupropion; Cerebral Cortex; Dopamine; Iontophoresis; Male; Methyltyrosines; Neurons; Neurotransmitter Uptake Inhibitors; Organ Specificity; Oxidopamine; Piperazines; Rats; Rats, Inbred Strains; Synapses | 1991 |
Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys.
Topics: Animals; Bupropion; Cocaine; Dopamine; Male; Mazindol; Methylphenidate; Neurotransmitter Uptake Inhibitors; Nomifensine; Piperazines; Propiophenones; Saimiri; Self Administration | 1989 |
Dissociation of the actions of uptake blockers upon dopamine overflow and uptake in the rat nucleus accumbens: in vivo voltammetric data.
Topics: Animals; Benztropine; Bupropion; Cocaine; Dopamine; Electric Stimulation; Electrochemistry; Levodopa; Male; Microelectrodes; Neurotransmitter Uptake Inhibitors; Nomifensine; Nucleus Accumbens; Piperazines; Propiophenones; Rats; Rats, Inbred Strains; Septal Nuclei | 1989 |
Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Benztropine; Bupropion; Caudate Nucleus; Dopamine; Electric Stimulation; Electrochemistry; Extracellular Space; Kinetics; Levodopa; Male; Microelectrodes; Neurotransmitter Uptake Inhibitors; Nomifensine; Piperazines; Propiophenones; Rats; Rats, Inbred Strains | 1988 |
The rate hypothesis and agonist substitution approaches to cocaine abuse treatment.
Topics: Animals; Bupropion; Cocaine; Dopamine Uptake Inhibitors; Humans; Mazindol; Piperazines; Substance-Related Disorders | 1998 |
Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.
Topics: Animals; Body Temperature; Bupropion; Cocaine; Discrimination, Psychological; Female; Male; Membrane Potentials; Mice; Mice, Inbred ICR; Molecular Structure; Motor Activity; Nicotine; Oocytes; Pain; Piperazines; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Recombinant Proteins; Seizures; Structure-Activity Relationship; Tropanes; Xenopus laevis | 1999 |
GBR-12909 effect on dopamine outflow depends on phosphorylation in the caudate nucleus of the rat.
Topics: Animals; Bupropion; Caudate Nucleus; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Enzyme Activators; Enzyme Inhibitors; Female; Nomifensine; Okadaic Acid; Organ Culture Techniques; Phosphoprotein Phosphatases; Phosphorylation; Piperazines; Protein Kinase C; Rats; Rats, Wistar; Sodium Channel Blockers | 2002 |
Role of dopamine in behavioral sensitization to ethanol in DBA/2J mice.
Topics: Animals; Behavior, Animal; Benzazepines; Bupropion; Central Nervous System Depressants; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Ethanol; Habituation, Psychophysiologic; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred DBA; Motor Activity; Nerve Tissue Proteins; Piperazines; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2005 |
Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications.
Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Bupropion; Cocaine; Conditioning, Operant; Conditioning, Psychological; Discrimination Learning; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Generalization, Psychological; Male; Methylphenidate; Nicotine; Nicotinic Antagonists; Piperazines; Propylamines; Rats; Rats, Sprague-Dawley | 2007 |
Blockade of dopamine, but not noradrenaline, transporters produces hyperthermia in rats that lack serotonin transporters.
Topics: Animals; Atomoxetine Hydrochloride; Body Temperature; Bupropion; Dopamine Plasma Membrane Transport Proteins; Fever; Injections; Male; Norepinephrine Plasma Membrane Transport Proteins; Piperazines; Propylamines; Rats; Serotonin Plasma Membrane Transport Proteins; Stress, Physiological | 2010 |
The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition.
Topics: Animals; Antidepressive Agents; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Desipramine; Diazepam; Dopamine Uptake Inhibitors; Fluvoxamine; Haloperidol; Imipramine; Male; Piperazines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology | 2011 |
Assessment of receptor occupancy-over-time of two dopamine transporter inhibitors by [(11)C]CIT and target controlled infusion.
Topics: Animals; Bupropion; Carbon Isotopes; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Half-Life; Macaca mulatta; Piperazines; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
Topics: Animals; Antidepressive Agents; Benzazepines; Bupropion; Choice Behavior; Desipramine; Dopamine Antagonists; Dose-Response Relationship, Drug; Fluoxetine; Haloperidol; Male; Motivation; Neurotransmitter Uptake Inhibitors; Piperazines; Rats, Sprague-Dawley; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2016 |